These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 8280789
1. Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease. Chiu HC, Jeng JR, Shieh SM. Biochim Biophys Acta; 1994 Jan 11; 1225(2):200-8. PubMed ID: 8280789 [Abstract] [Full Text] [Related]
2. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia]. Deng Z, Liu B, Zhou J, Zhang Z, Liu Y, Bai H. Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct 11; 34(4):704-7. PubMed ID: 14619587 [Abstract] [Full Text] [Related]
3. Oxidative modification of lipoproteins in hypertriglyceridemic patients and hypercholesterolemic rabbits in vivo. Liu BW, Jiang Y, Fu MD, Liu Y, Fan P. Mol Cell Biochem; 2000 Apr 11; 207(1-2):131-5. PubMed ID: 10888238 [Abstract] [Full Text] [Related]
4. A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation. Zhang A, Vertommen J, Van Gaal L, De Leeuw I. Clin Chim Acta; 1994 Jun 11; 227(1-2):159-73. PubMed ID: 7955412 [Abstract] [Full Text] [Related]
5. Consequences of treatment with dexamethasone in rats on the susceptibility of total plasma and isolated lipoprotein fractions to copper oxidation. Belkebir-Mesbah D, Bonnefont-Rousselot D, Frey-Fressart V, Moinard C, Delattre J, Vasson MP. Endocrine; 1999 Jun 11; 10(3):233-42. PubMed ID: 10484287 [Abstract] [Full Text] [Related]
6. Plasma lipid oxidation and susceptibility of low-density lipoproteins to oxidation in male patients with stable coronary artery disease. Karmansky I, Shnaider H, Palant A, Gruener N. Clin Biochem; 1996 Dec 11; 29(6):573-9. PubMed ID: 8939406 [Abstract] [Full Text] [Related]
7. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography. Whayne TF, Alaupovic P, Curry MD, Lee ET, Anderson PS, Schechter E. Atherosclerosis; 1981 Jun 11; 39(3):411-24. PubMed ID: 6942843 [Abstract] [Full Text] [Related]
8. Identification of oxidized low-density lipoprotein in human serum by NMR spectroscopy. Jankowski J, Nofer JR, Tepel M, Griewel B, Schlüter H, Assmann G, Zidek W. Clin Sci (Lond); 1998 Oct 11; 95(4):489-95. PubMed ID: 9748425 [Abstract] [Full Text] [Related]
9. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia. Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, Ruocco A, Ambrosio G, Montefusco S, Malorni A, Condorelli M, Chiariello M. Atherosclerosis; 1995 Dec 11; 118(2):259-73. PubMed ID: 8770320 [Abstract] [Full Text] [Related]
10. Lipoprotein peroxidation in adult psoriatic patients. Offidani AM, Ferretti G, Taus M, Simonetti O, Dousset N, Valdiguie P, Curatola G, Bossi G. Acta Derm Venereol Suppl (Stockh); 1994 Dec 11; 186():38-40. PubMed ID: 8073834 [Abstract] [Full Text] [Related]
11. Effect of cholesterol feeding on the susceptibility of lipoproteins to oxidative modification. Nenseter MS, Gudmundsen O, Malterud KE, Berg T, Drevon CA. Biochim Biophys Acta; 1994 Jul 14; 1213(2):207-14. PubMed ID: 8025132 [Abstract] [Full Text] [Related]
12. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients. Jain SK, McVie R, Jaramillo JJ, Chen Y. Free Radic Biol Med; 1998 Jan 01; 24(1):175-81. PubMed ID: 9436628 [Abstract] [Full Text] [Related]
13. Effect of gemfibrozil on the composition and oxidation properties of very-low-density lipoprotein and high-density lipoprotein in patients with hypertriglyceridemia. Hsu HC, Lee YT, Yeh HT, Chen MF. J Lab Clin Med; 2001 Jun 01; 137(6):414-21. PubMed ID: 11385362 [Abstract] [Full Text] [Related]
14. [Oxidative modification of serum LDL, VLDL and HDL induced by fed on high cholesterol diet in vivo in rabbits]. Jiang Y, Liu B, Fu M. Hua Xi Yi Ke Da Xue Xue Bao; 1997 Mar 01; 28(1):1-5. PubMed ID: 10684051 [Abstract] [Full Text] [Related]
15. [Investigation of peroxide modification of low- and very low-density lipoproteins in patients with coronary heart disease by the method of fluorescent spectroscopy]. Aĭdyraliev RK, Igemberdieva OA, Dadabaev MKh, Murataliev TM, Aĭtbaev KA, Aldashev AA. Biomed Khim; 2011 Mar 01; 57(1):127-32. PubMed ID: 21516784 [Abstract] [Full Text] [Related]
16. Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients. Chen MF, Wang TD, Yeh HT, Hsu HC, Lee YT. Eur J Clin Invest; 2001 Aug 01; 31(8):707-13. PubMed ID: 11473572 [Abstract] [Full Text] [Related]
17. Possible role of high susceptibility of high-density lipoprotein to lipid peroxidative modification and oxidized high-density lipoprotein in genesis of coronary artery spasm. Ohmura H, Watanabe Y, Hatsumi C, Sato H, Daida H, Mokuno H, Yamaguchi H. Atherosclerosis; 1999 Jan 01; 142(1):179-84. PubMed ID: 9920519 [Abstract] [Full Text] [Related]
18. [Effect of Huajiao volatile oil on Cu2+ -induced oxidative modification of low density lipoprotein in vitro]. Ma JY, Shi YK, Fang DZ. Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan 01; 37(1):63-5. PubMed ID: 16468644 [Abstract] [Full Text] [Related]
19. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Fuller CJ, Grundy SM, Norkus EP, Jialal I. Atherosclerosis; 1996 Jan 26; 119(2):139-50. PubMed ID: 8808491 [Abstract] [Full Text] [Related]
20. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, Leboeuf N, Boulet L, de Langavant GC, Davignon J, Naruszewicz M. Arterioscler Thromb; 1993 Dec 26; 13(12):1790-7. PubMed ID: 8241099 [Abstract] [Full Text] [Related] Page: [Next] [New Search]